Gyros Japan KK provides sales, field applications and service for the immunoassay business

Gyros Protein Technologies AB, a pioneer in automated nanoliter-scale immunoassays and leading provider of peptide synthesizers and reagents, today announced it has established a dedicated office in Tokyo, Japan and has established Gyros Japan KK.

The dedicated Japan team provides sales, applications and service support in Japan for the Company’s Gyros’ immunoassay business. Gyros Japan KK replaces support previously provided under the distribution agreement in Japan with GE Healthcare for Gyros Protein Technologies’ nanoliter-scale immunoassay platform business (Gyrolab xP workstation, Gyrolab xPlore, related reagents, consumables and service).

GE Healthcare will continue providing support for sales, technical support and maintenance service until the end of December 2016. Gyros Japan KK will take over full responsibility for the region from January 2017, ensuring a smooth transition for customers.

Peter Luk, Vice President Asia-Pacific, Gyros Protein Technologies, said: “We are delighted to announce the opening of the Japan office, and would like to thank GE Healthcare for their continued support during this transition period. This marks an important development for Gyros Protein Technologies and demonstrates the company’s commitment to the Asia-Pacific region, which has seen significant growth in the biotherapeutic discovery, development and manufacturing markets in recent years.”

more about gyros protein technologies

more news from gyros